Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anderson GSF"'
Autor:
Anderson GSF; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK., Chapman MA; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK; Addenbrooke's Hospital, Cambridge Universities Foundation Trust, Cambridge CB2 0QQ, UK. Electronic address: mac54@cam.ac.uk.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Sep 04; Vol. 32 (9), pp. 2856-2891. Date of Electronic Publication: 2024 Aug 05.
Autor:
Walker IG; MRC Toxicology Unit, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Addenbrooke's Hospital, Cambridge Universities Foundation Trust, Cambridge, UK., Roy JP; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Anderson GSF; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Guerrero Lopez J; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Chapman MA; MRC Toxicology Unit, University of Cambridge, Cambridge, UK. mac54@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. mac54@cam.ac.uk.; Addenbrooke's Hospital, Cambridge Universities Foundation Trust, Cambridge, UK. mac54@cam.ac.uk.
Publikováno v:
Leukemia [Leukemia] 2024 Aug; Vol. 38 (8), pp. 1848-1852. Date of Electronic Publication: 2024 Apr 30.
Autor:
Yam-Puc JC; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK. jcy28@cam.ac.uk., Hosseini Z; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Horner EC; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Gerber PP; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Beristain-Covarrubias N; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Hughes R; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Lulla A; Department of Biochemistry, University of Cambridge, Cambridge, UK., Rust M; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Boston R; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Ali M; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Fischer K; Department of Biochemistry, University of Cambridge, Cambridge, UK., Simmons-Rosello E; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., O'Reilly M; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Robson H; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Booth LH; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Kahanawita L; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Correa-Noguera A; Department of Oncology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Favara D; Department of Oncology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Immunology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Keller B; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Craxton A; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Anderson GSF; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Sun XM; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Elmer A; NIHR Cambridge Clinical Research Facility, Cambridge, UK., Saunders C; NIHR Cambridge Clinical Research Facility, Cambridge, UK., Bermperi A; NIHR Cambridge Clinical Research Facility, Cambridge, UK., Jose S; NIHR Cambridge Clinical Research Facility, Cambridge, UK., Kingston N; NIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Mulroney TE; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Piñon LPG; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Chapman MA; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Grigoriadou S; Department of Clinical Immunology, Barts Health, London, UK., MacFarlane M; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Willis AE; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Patil KR; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Spencer S; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK., Staples E; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK.; Department of Clinical Immunology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Warnatz K; Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Immunology, University Hospital Zurich, Zurich, Switzerland., Buckland MS; Department of Clinical Immunology, Barts Health, London, UK.; UCL GOSH Institute of Child Health Division of Infection and Immunity, Section of Cellular and Molecular Immunology, London, UK., Hollfelder F; Department of Biochemistry, University of Cambridge, Cambridge, UK., Hyvönen M; Department of Biochemistry, University of Cambridge, Cambridge, UK., Döffinger R; Department of Clinical Immunology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Parkinson C; Department of Oncology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Lear S; Department of Clinical Immunology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Matheson NJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; NHS Blood and Transplant, Cambridge, UK., Thaventhiran JED; Medical Research Council Toxicology Unit, School of Biological Sciences, University of Cambridge, Cambridge, UK. jedt2@cam.ac.uk.; Department of Clinical Immunology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. jedt2@cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Jun 27; Vol. 14 (1), pp. 3292. Date of Electronic Publication: 2023 Jun 27.
Autor:
Pereira C; Cambridge Institute for Medical Research, University of Cambridge , Cambridge, UK., Stalder D; Cambridge Institute for Medical Research, University of Cambridge , Cambridge, UK., Anderson GSF; MRC Toxicology Unit, University of Cambridge , Cambridge, UK., Shun-Shion AS; Metabolic Research Laboratory, Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge , Cambridge, UK., Houghton J; Cambridge Institute for Medical Research, University of Cambridge , Cambridge, UK., Antrobus R; Cambridge Institute for Medical Research, University of Cambridge , Cambridge, UK., Chapman MA; MRC Toxicology Unit, University of Cambridge , Cambridge, UK., Fazakerley DJ; Metabolic Research Laboratory, Wellcome-Medical Research Council Institute of Metabolic Science, University of Cambridge , Cambridge, UK., Gershlick DC; Cambridge Institute for Medical Research, University of Cambridge , Cambridge, UK.
Publikováno v:
The Journal of cell biology [J Cell Biol] 2023 May 01; Vol. 222 (5). Date of Electronic Publication: 2023 Mar 15.
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.
Autor:
Anderson GSF; MRC Toxicology Unit and.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Ballester-Beltran J; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Giotopoulos G; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom., Guerrero JA; MRC Toxicology Unit and., Surget S; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Williamson JC; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., So T; MRC Toxicology Unit and., Bloxham D; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Aubareda A; MRC Toxicology Unit and.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Asby R; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom., Walker I; MRC Toxicology Unit and.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Jenkinson L; CRUK-AstraZeneca Antibody Alliance Laboratory, Cambridge, United Kingdom., Soilleux EJ; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Roy JP; MRC Toxicology Unit and., Teodósio A; MRC Toxicology Unit and., Ficken C; MRC Toxicology Unit and., Officer-Jones L; MRC Toxicology Unit and., Nasser S; Translational Genomics Research Institute, Phoenix, AZ., Skerget S; Translational Genomics Research Institute, Phoenix, AZ., Keats JJ; Translational Genomics Research Institute, Phoenix, AZ., Greaves P; Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom., Tai YT; Dana Farber Cancer Institute, Boston, MA; and., Anderson KC; Dana Farber Cancer Institute, Boston, MA; and., MacFarlane M; MRC Toxicology Unit and., Thaventhiran JE; MRC Toxicology Unit and., Huntly BJP; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom., Lehner PJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom., Chapman MA; MRC Toxicology Unit and.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Publikováno v:
Blood [Blood] 2022 Apr 21; Vol. 139 (16), pp. 2471-2482.
Autor:
Parol W; University of Cambridge, MRC Toxicology Unit, Cambridge, UK., Anderson GSF; University of Cambridge, MRC Toxicology Unit, Cambridge, UK., Chapman MA; University of Cambridge, MRC Toxicology Unit, Cambridge, UK.
Publikováno v:
Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2022 Apr; Vol. 18 (4), pp. 241-244. Date of Electronic Publication: 2022 Jun 13.